6505--Bevacizumab

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79720R0038
Agency
National Acquisition Center Headquarters, Department of Veterans Affairs
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals

Notice details come from SAM.gov. Updated .

About this opportunity

This notice announces a pre-solicitation for Request for Proposal 36E79720R0038 to procure an unrestricted supply of Bevacizumab for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract will have a one year base period and four one-year option periods. Offerors must provide the exact brand name and National Drug Code number for the drug to be supplied. The solicitation will be issued electronically on May 21, 2020 with responses due by June 4, 2020.

No set-aside designation will be used. The NAICS code is 325412 for Pharmaceutical Preparation Manufacturing. The estimated annual requirements are 35,277 vials of 100mg Bevacizumab and 8,034 vials of 400mg Bevacizumab. Questions regarding this pre-solicitation must be submitted to the point of contact Stevan Vasich by the response deadline of June 4, 2020.

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0038 for an unrestrictive procurement Bevacizumab, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation #36E79720R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 21st, 2020, with a tentative closing date of June 4th, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download on Contract Opportunities at the following URL: https://beta.sam.gov/search?index=opp. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@.gov.

Attachments

Files attached to this notice, newest first
File Type Posted
36E79720R0038-001.docx DOCX document

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
6505--Zirabev (bevacizumab-bvzr) Effective 8/13/2020 - 8/12/2021 Award Award Notice
6505--Bevacizumab Latest solicitation Solicitation
6505--Bevacizumab This notice · Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity